Ptc Therapeutics (PTCT) EBT Margin (2012 - 2026)
Ptc Therapeutics (PTCT) recorded quarterly EBT Margin of 0.9% in Q1 2026, up 99.89% quarter-over-quarter from 843.41% in Q4 2025, and down 7996.0% on a YoY basis from 0.01% in Q1 2025.
Ptc Therapeutics (PTCT) EBT Margin (2012 - 2026) Analysis & Trends
Ptc Therapeutics' EBT Margin history runs 15 years deep, the most recent figure standing at 0.9% for Q1 2026.
- In Q1 2026, EBT Margin fell 7996.0% year-over-year to 0.9%; the TTM figure through Mar 2026 stood at 179.6% (down 22067.0% YoY), while the FY2025 annual figure was 31.96%, up 1304.0% from the prior year.
- EBT Margin was 0.9% for Q1 2026 at Ptc Therapeutics, up from 843.41% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 204.42% in Q4 2023 to a low of 843.41% in Q4 2025.
- Historically, EBT Margin has averaged 84.31% across 5 years, with a median of 54.19% in 2022.
- The sharpest annual moves came in 2023 and 2025: EBT Margin surged 31991 bps in 2023, then plunged 79898 bps in 2025.
- A 5-year view of EBT Margin shows it stood at 115.48% in 2022, then surged by 277 bps to 204.42% in 2023, then slumped by 122 bps to 44.42% in 2024, then plunged by 1799 bps to 843.41% in 2025, then soared by 100 bps to 0.9% in 2026.
- The last three EBT Margin figures came in at 0.9% (Q1 2026), 843.41% (Q4 2025), and 10.94% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ptc Therapeutics | 6.51 Bn | 4.61 Bn | 244.52 Mn | -0.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.90% |
| Dec 31, 2025 | -843.41% |
| Sep 30, 2025 | -10.94% |
| Jun 30, 2025 | -39.72% |
| Mar 31, 2025 | 79.06% |
| Dec 31, 2024 | -44.42% |
| Sep 30, 2024 | -49.80% |
| Mar 31, 2024 | -40.31% |
| Dec 31, 2023 | 204.42% |
| Sep 30, 2023 | -84.75% |
| Jun 30, 2023 | -111.07% |
| Mar 31, 2023 | -61.25% |
| Dec 31, 2022 | -115.48% |
| Sep 30, 2022 | -58.59% |
| Jun 30, 2022 | -89.83% |
| Mar 31, 2022 | -81.95% |
| Dec 31, 2021 | -83.89% |
| Sep 30, 2021 | -96.34% |
| Jun 30, 2021 | -101.03% |
| Mar 31, 2021 | -108.69% |